Stock comparison
Ironwood Pharmaceuticals
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IRWD
Ironwood Pharmaceuticals
Market cap
$645.28M
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IRWD | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 47D | 69B | MTD |
| Benjamin Graham | 25F | 65B | MTD |
| Philip Fisher | 41D | 63C | MTD |
| Peter Lynch | 26F | 66B | MTD |
| Joel Greenblatt | 69B | 68B | IRWD |
| Charlie Munger | 68D | 74B | MTD |
| Terry Smith | 66C | 70B | MTD |
Side-by-side metrics
| Metric | IRWD | MTD |
|---|---|---|
| Market cap | $645.28M | $22.29B |
| P/E (TTM) | 4.5x | 25.3x |
| EV/EBIT | 9.0x | 21.6x |
| ROIC (TTM) | 43.86% | 36.09% |
| Gross margin | 99.75% | 57.79% |
| Net margin | 41.76% | 21.4% |
| Revenue CAGR 5y | -8.02% | 2.01% |
| EPS CAGR 5y | -53.69% | 6.12% |
| Debt / Equity | - | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IRWD leads on
- P/E (TTM)4.5xvs 25.3x+82%
- EV/EBIT9.0xvs 21.6x+59%
- Net margin41.76%vs 21.4%+49%
- Gross margin99.75%vs 57.79%+42%
MTD leads on
- Revenue CAGR 5y2.01%vs -8.02%+125%
- EPS CAGR 5y6.12%vs -53.69%+111%
- Market cap$22.29Bvs $645.28M+97%
- Debt / Equity-vs -+95%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.